Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Takeda Pharmaceutical Company Stories

2013-12-26 12:21:06

NEW YORK, Dec. 26, 2013 /PRNewswire/ -- The federal multidistrict litigation established for Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) that allege use of the Type 2 diabetes drug caused patients to develop bladder cancer continues to move forward in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to court documents, the proceeding's next Status Conference has been scheduled for January 23, 2014 at 10:30...

2013-12-24 12:21:43

Crohn's disease action date remains unchanged DEERFIELD, Ill. and OSAKA, Japan, Dec. 24, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food & Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) Priority Review action date for the ulcerative colitis (UC) indication of Takeda's investigational biologic,...

2013-12-18 04:20:39

ZURICH, Switzerland, December 18, 2013 /PRNewswire/ -- Demonstrates Takeda's commitment to bring new, innovative treatments to patients Takeda Pharmaceuticals International GmbH ("Takeda") today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth...

2013-12-14 23:01:52

The Firm is evaluating Actos lawsuits on behalf of individuals stricken with bladder cancer, allegedly due to extended use of the Type 2 diabetes medication. New York, New York (PRWEB) December 14, 2013 More than 2,600 Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to court documents, a Status...

2013-12-09 23:26:49

Number of cases climbs to 2,641 in multidistrict litigation as attorneys prepare for first bellwether trial. Resource4thePeople maintains offer of free consultations to consumers seeking compensation over bladder cancer allegations. San Diego, Ca (PRWEB) December 09, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople announced today the latest developments for consumers affected by litigation involving allegations that the diabetes...

2013-12-09 23:02:21

The Firm is investigating Actos lawsuits on behalf of individuals who allegedly developed bladder cancer due to long-term use of Actos. New York, New York (PRWEB) December 09, 2013 The nation’s third trial of an Actos lawsuit (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) involving allegations that long-term use of the Type 2 diabetes drug can cause bladder cancer is now underway in the Eighth Judicial District Court of Nevada for Clarks County, Bernstein Liebhard LLP...

2013-12-09 20:23:04

Takeda announces positive vote on vedolizumab to treat ulcerative colitis and Crohn's disease DEERFIELD, Ill. and OSAKA, Japan, Dec. 9, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States (U.S.) Food and Drug Administration (FDA) voted to...

2013-11-15 23:24:43

Four men are each seeking more than $1.75 million over allegations that they suffered bladder cancer after diabetes treatments. Resource4thePeople announces continuation of offer of free consultations to consumers seeking compensation over bladder cancer allegations. San Diego, CA (PRWEB) November 15, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople announced today its latest update for consumers who have been following litigation...

2013-11-14 12:26:55

Company's Outstanding Benefits, Work/Life Balance and Rewarding Career Opportunities Support Ranking DEERFIELD, Ill., Nov. 14, 2013 /PRNewswire/ -- Takeda Pharmaceuticals announced today that the Chicago Tribune named Takeda's Deerfield campus among Chicago's Top 100 Workplaces in 2013. The Chicago Tribune's Top Workplaces list is determined by anonymous feedback from employees of participating companies who credited their employers with having dynamic, supportive and inclusive cultures. "To...

2013-11-13 23:19:48

Reportbuyer.com just published a new market research report: PharmaSphere: Asia Pacific Deal Trends, 2004–2013. London (PRWEB) November 13, 2013 PharmaSphere: Asia Pacific Deal Trends, 2004–2013 Summary GlobalData’s report, "PharmaSphere: Asia Pacific Deal Trends, 2004–2013" offers an in-depth understanding of the key deals that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing...